The net profit of Danish pharmaceutical company LEO Pharma peaked in 2014 at 1.54 billion Danish kroner. The following years, the company made profits, but fluctuating. In 2021 and 2022, net losses amounted to record highs of around 4.9 billion and 4.1 billion Danish kroner, respectively. Leo Pharma is a Danish pharmaceutical company founded 1908. The company's key products are dermatological pharmaceuticals.
Net profit/loss of LEO Pharma from 2009 to 2023
(in million DKK)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
LEO Pharma. (February 28, 2024). Net profit/loss of LEO Pharma from 2009 to 2023 (in million DKK) [Graph]. In Statista. Retrieved November 21, 2024, from https://www.statista.com/statistics/954250/net-profit-of-leo-pharma/
LEO Pharma. "Net profit/loss of LEO Pharma from 2009 to 2023 (in million DKK) ." Chart. February 28, 2024. Statista. Accessed November 21, 2024. https://www.statista.com/statistics/954250/net-profit-of-leo-pharma/
LEO Pharma. (2024). Net profit/loss of LEO Pharma from 2009 to 2023 (in million DKK) . Statista. Statista Inc.. Accessed: November 21, 2024. https://www.statista.com/statistics/954250/net-profit-of-leo-pharma/
LEO Pharma. "Net Profit/Loss of Leo Pharma from 2009 to 2023 (in Million Dkk) ." Statista, Statista Inc., 28 Feb 2024, https://www.statista.com/statistics/954250/net-profit-of-leo-pharma/
LEO Pharma, Net profit/loss of LEO Pharma from 2009 to 2023 (in million DKK) Statista, https://www.statista.com/statistics/954250/net-profit-of-leo-pharma/ (last visited November 21, 2024)
Net profit/loss of LEO Pharma from 2009 to 2023 (in million DKK) [Graph], LEO Pharma, February 28, 2024. [Online]. Available: https://www.statista.com/statistics/954250/net-profit-of-leo-pharma/
